BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 27, 2011
View Archived Issues
Clinical data presented on several AstraZeneca products in solid tumors
Read More
Boehringer Ingelheim claims new HCV serine protease NS3 inhibitors
Read More
Z-123212 reverses symptoms of neuropathic pain by state-dependent inhibition of ion channels
Read More
Galderma presents new matrix metalloproteinase inhibitors for rosacea
Read More
Scientists at GSK disclose novel fatty acid synthase inhibitors
Read More
Final data presented from phase I trial of X-Excite versus Viagra
Read More
Phase II trial assesses second-line danusertib in metastatic castration-resistant prostate cancer
Read More
Interim first-in-human data support safety/activity of INCB-028060 in advanced solid tumors
Read More
Combination of lorvotuzumab mertansine, dexamethasone and lenalidomide is safe in multiple myeloma
Read More
Belatacept remains superior to ciclosporin after 3 years of treatment in BENEFIT trial
Read More
New dUPTase inhibitors for cancer prepared at Taiho
Read More
Daiichi Sankyo patents novel renin inhibitors
Read More
GSK begins phase II GSK-2251052 trials in urinary tract and intra-abdominal infections
Read More
Rectiv approved in U.S. for pain associated with chronic anal fissures
Read More
RG-3039 receives FDA fast track status for spinal muscular atrophy
Read More
Meda files MAA with EMA for Zyclara
Read More
Naurex begins phase II trial of novel antidepressant GLYX-13
Read More
Tobira Therapeutics begins phase IIb cenicriviroc trial in HIV infection
Read More
Rexahn Pharmaceuticals completes enrollment in phase IIb Serdaxin trial
Read More
FDA committee votes against approval of canakinumab in gouty arthritis
Read More
CHMP recommends approval of linagliptin for type 2 diabetes
Read More
EMA accepts for review Eisai's perampanel MAA for partial-onset seizures
Read More
New phase Ib study to assess TMC-649128 in genotype 1 hepatitis C
Read More
EMA accepts Adcetris MAA in Hodgkin's and systemic anaplastic large cell lymphoma
Read More
FDA issues complete response letter on Remoxy
Read More
E.U. approval recommended for Votubia in TSC-associated subependymal giant cell astrocytoma
Read More